- $271.51m
- $220.51m
- $212.45m
- 75
- 26
- 67
- 56
Annual balance sheet for LifeMD, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 9.18 | 41.3 | 3.96 | 33.1 | 35 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.998 | 0.98 | 2.83 | 5.28 | 8.22 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 12.4 | 44.9 | 11.3 | 42.6 | 48.7 |
Net Property, Plant And Equipment | 0.274 | 1.99 | 1.68 | 1.07 | 7.88 |
Net Intangible Assets | |||||
Total Assets | 13.4 | 49.9 | 25.7 | 58.5 | 72.5 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13.9 | 22.8 | 31.4 | 34.8 | 60.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 12 | 23.1 | 32.5 | 55 | 77.9 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 1.35 | 26.9 | -6.83 | 3.51 | -5.49 |
Total Liabilities & Shareholders' Equity | 13.4 | 49.9 | 25.7 | 58.5 | 72.5 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |